# SUI Group Holdings Ltd.: financial statements, quarterly

SUIG · Nasdaq · CIK 1425355 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/suig.md) · [Financials](/companies/suig/financials.md) · [Filings](/companies/suig/filings.md) · [Insiders](/companies/suig/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/suig/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [0.7](/filings/0001654954-25-012949.md) | [0.9 d](/filings/0001654954-26-001672.md) | [0.8](/filings/0001654954-26-004627.md) | [0.9](/filings/0001654954-26-007355.md) | [1.0](/filings/0001654954-25-012949.md) | [1.2 d](/filings/0001654954-26-001672.md) | [0.6](/filings/0001654954-26-004627.md) | [0.4](/filings/0001654954-26-007355.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | not reported | not reported | [0.6](/filings/0001654954-25-012949.md) | [(0.1) d](/filings/0001654954-26-001672.md) | [0.6](/filings/0001654954-26-004627.md) | [0.9](/filings/0001654954-26-007355.md) | [(63.7)](/filings/0001654954-25-012949.md) | [(202) d](/filings/0001654954-26-001672.md) | [(60.5)](/filings/0001654954-26-004627.md) | [(19.7)](/filings/0001654954-26-007355.md) |
| Interest expense | $m | [0.0](/filings/0001654954-24-014099.md) | [0.0 d](/filings/0001654954-24-004122.md) | [0.0](/filings/0001654954-24-006409.md) | [0.0](/filings/0001654954-24-010649.md) | [0.0](/filings/0001654954-24-014099.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.1)](/filings/0001654954-24-014099.md) | [(0.4) d](/filings/0001654954-25-002487.md) | [0.2](/filings/0001654954-25-005448.md) | [0.1](/filings/0001654954-25-009666.md) | [0.1](/filings/0001654954-25-012949.md) | [(0.0) d](/filings/0001654954-26-001672.md) | [0.1](/filings/0001654954-26-004627.md) | [0.3](/filings/0001654954-26-007355.md) | [(17.2)](/filings/0001654954-25-012949.md) | [17.6 d](/filings/0001654954-26-001672.md) | [0.0](/filings/0001654954-26-004627.md) | [0.0](/filings/0001654954-26-007355.md) |
| Net income | $m | not reported | not reported | not reported | not reported | [0.5](/filings/0001654954-25-012949.md) | [(0.1) d](/filings/0001654954-26-001672.md) | [0.5](/filings/0001654954-26-004627.md) | [0.7](/filings/0001654954-26-007355.md) | [(44.3)](/filings/0001654954-25-012949.md) | [(222) d](/filings/0001654954-26-001672.md) | [(70.9)](/filings/0001654954-26-004627.md) | [(18.9)](/filings/0001654954-26-007355.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001654954-24-014099.md) | not reported | not reported | [0.06](/filings/0001654954-24-010649.md) | [0.07](/filings/0001654954-25-012949.md) | not reported | [0.07](/filings/0001654954-26-004627.md) | [0.11](/filings/0001654954-26-007355.md) | [(0.72)](/filings/0001654954-25-012949.md) | not reported | [(0.88)](/filings/0001654954-26-004627.md) | [(0.23)](/filings/0001654954-26-007355.md) |
| Basic EPS | $ per share | [0.06](/filings/0001654954-24-014099.md) | not reported | not reported | [0.06](/filings/0001654954-24-010649.md) | [0.07](/filings/0001654954-25-012949.md) | not reported | [0.07](/filings/0001654954-26-004627.md) | [0.11](/filings/0001654954-26-007355.md) | [(0.72)](/filings/0001654954-25-012949.md) | not reported | [(0.88)](/filings/0001654954-26-004627.md) | [(0.23)](/filings/0001654954-26-007355.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.0](/filings/0001654954-23-014555.md) | [0.4](/filings/0001654954-25-002487.md) | not reported | not reported | not reported | [6.0](/filings/0001654954-26-001672.md) | [1.7](/filings/0001654954-25-005448.md) | [1.5](/filings/0001654954-25-009666.md) | not reported | not reported | not reported | not reported |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [20.5](/filings/0001654954-26-001672.md) | not reported | not reported | [74.4](/filings/0001654954-25-012949.md) | [30.3](/filings/0001654954-26-007355.md) | [10.0](/filings/0001654954-26-004627.md) | [7.5](/filings/0001654954-26-007355.md) |
| Total assets | $m | [19.6](/filings/0001654954-23-014555.md) | [19.1](/filings/0001654954-25-002487.md) | [19.0](/filings/0001654954-24-006409.md) | [19.7](/filings/0001654954-24-010649.md) | [20.3](/filings/0001654954-24-014099.md) | [20.5](/filings/0001654954-26-001672.md) | [19.8](/filings/0001654954-25-005448.md) | [20.4](/filings/0001654954-25-009666.md) | [429](/filings/0001654954-25-012949.md) | [190](/filings/0001654954-26-007355.md) | [119](/filings/0001654954-26-004627.md) | [97.9](/filings/0001654954-26-007355.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [0.7](/filings/0001654954-26-001672.md) | not reported | not reported | [13.2](/filings/0001654954-25-012949.md) | [12.7](/filings/0001654954-26-007355.md) | [13.0](/filings/0001654954-26-004627.md) | [12.1](/filings/0001654954-26-007355.md) |
| Total liabilities | $m | [0.1](/filings/0001654954-23-014555.md) | [0.5](/filings/0001654954-25-002487.md) | [0.0](/filings/0001654954-24-006409.md) | [0.3](/filings/0001654954-24-010649.md) | [0.5](/filings/0001654954-24-014099.md) | [0.7](/filings/0001654954-26-001672.md) | [0.3](/filings/0001654954-25-005448.md) | [0.2](/filings/0001654954-25-009666.md) | [24.0](/filings/0001654954-25-012949.md) | [20.6](/filings/0001654954-26-007355.md) | [18.0](/filings/0001654954-26-004627.md) | [14.1](/filings/0001654954-26-007355.md) |
| Shareholders' equity | $m | [19.5](/filings/0001654954-24-014099.md) | [18.6](/filings/0001654954-26-001672.md) | [19.0](/filings/0001654954-25-009666.md) | [19.4](/filings/0001654954-25-012949.md) | [19.8](/filings/0001654954-25-012949.md) | [19.8](/filings/0001654954-26-007355.md) | [19.6](/filings/0001654954-26-007355.md) | [20.3](/filings/0001654954-26-007355.md) | [405](/filings/0001654954-25-012949.md) | [170](/filings/0001654954-26-007355.md) | [101](/filings/0001654954-26-007355.md) | [83.8](/filings/0001654954-26-007355.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.6) d](/filings/0001654954-24-014099.md) | [(0.6) d](/filings/0001654954-25-002487.md) | [0.1](/filings/0001654954-25-005448.md) | [4.9 d](/filings/0001654954-25-009666.md) | [(3.8) d](/filings/0001654954-25-012949.md) | [4.4 d](/filings/0001654954-26-001672.md) | [(3.6)](/filings/0001654954-26-004627.md) | [(0.3) d](/filings/0001654954-26-007355.md) | [2.1 d](/filings/0001654954-25-012949.md) | [(6.5) d](/filings/0001654954-26-001672.md) | [(1.8)](/filings/0001654954-26-004627.md) | [(1.9) d](/filings/0001654954-26-007355.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001654954-25-012949.md) | [0.0 d](/filings/0001654954-26-001672.md) | [0.6](/filings/0001654954-26-004627.md) | [(0.0) d](/filings/0001654954-26-007355.md) | [2.6 d](/filings/0001654954-25-012949.md) | [15.7 d](/filings/0001654954-26-001672.md) | [0.0](/filings/0001654954-26-004627.md) | [0.0 d](/filings/0001654954-26-007355.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q1 FY2023 (2023-03-31) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.8](/filings/0001104659-21-137768.md) | [4.8](/filings/0001654954-25-005448.md) | [10.8](/filings/0001410578-22-002643.md) | [6.2](/filings/0001654954-25-005448.md) | [6.4](/filings/0001654954-24-014099.md) | [6.5](/filings/0001654954-25-005448.md) | [6.5](/filings/0001654954-25-012949.md) | [6.4](/filings/0001654954-26-004627.md) | [6.1](/filings/0001654954-26-007355.md) | [61.1](/filings/0001654954-25-012949.md) | [80.9](/filings/0001654954-26-004627.md) | [80.9](/filings/0001654954-26-007355.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 76,802,872 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001654954-26-007355.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.